While a major driver of AR-V7 expression in prostate cancer is transcriptional activation, the significance of deregulation of post-transcriptional mechanisms (beyond splicing regulation) in AR-V7 is becoming more apparent (97). This evidence concerns the gene AR and prostate carcinoma.